PHASE-1 TRIAL OF MITOXANTRONE BY 24-HOUR CONTINUOUS INFUSION

被引：0
|
作者：
ANDERSON, KC
GARNICK, MB
MESHAD, MW
COHEN, GI
PEGG, WJ
FREI, E
ISRAEL, M
MODEST, E
CANELLOS, GP
机构：
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：435 / 438
页数：4
相关论文
共 50 条
  • [11] PHASE-I TRIAL OF ECHINOMYCIN (NSC-526417), A BIFUNCTIONAL INTERCALATING AGENT, ADMINISTERED BY 24-HOUR CONTINUOUS INFUSION
    KUHN, JG
    VONHOFF, DD
    HERSH, M
    MELINK, T
    CLARK, GM
    WEISS, GR
    COLTMAN, CA
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05): : 797 - 803
  • [12] A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
    JAYSON, GC
    CROWTHER, D
    PRENDIVILLE, J
    MCGOWN, AT
    SCHEID, C
    STERN, P
    YOUNG, R
    BRENCHLEY, P
    CHANG, J
    OWENS, S
    PETTIT, GR
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 461 - 468
  • [13] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED BY A 24-HOUR CONTINUOUS-INFUSION
    VANWARMERDAM, LJC
    HUININK, WWB
    RODENHUIS, S
    KOIER, I
    DAVIES, BE
    ROSING, H
    MAES, RAA
    BEIJNEN, JH
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1768 - 1776
  • [14] Clinical and pharmacokinetic phase I study with Cematodin(R) given as continuous 24-hour intravenous infusion
    Mross, K
    Fiebig, HH
    Berdel, W
    Bankmann, Y
    vonBroen, IM
    Walter, N
    Unger, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1122 - 1122
  • [15] A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma
    A R Clamp
    F H Blackhall
    P Vasey
    M Soukop
    R Coleman
    G Halbert
    L Robson
    G C Jayson
    British Journal of Cancer, 2003, 89 : 1152 - 1154
  • [16] A Phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies
    Pinguet, F
    Culine, S
    Bressolle, F
    Astre, C
    Serre, MP
    Chevillard, C
    Fabbro, M
    CLINICAL CANCER RESEARCH, 2000, 6 (01) : 57 - 63
  • [17] Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group Trial 9246
    Press, OW
    LeBlanc, M
    O'Rourke, TJ
    Gagnet, S
    Chapman, RA
    Balcerzak, SP
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 574 - 578
  • [18] PHASE-I STUDY OF PENTAMETHYLMELAMINE (PMM) BY 24-HOUR INFUSION
    CASPER, ES
    ALCOCK, NW
    KELSEN, DP
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 178 - 178
  • [19] Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion
    Chambers, Stephen T.
    Long, Madeleine
    Gardiner, Sharon J.
    Chin, Paul K. L.
    Yi, Ma
    Dalton, Simon C.
    Drennan, Philip G.
    Metcalf, Sarah C. L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (06)
  • [20] Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma
    Eckel, F
    Schmelz, R
    Erdmann, J
    Mayr, M
    Lersch, C
    CANCER INVESTIGATION, 2003, 21 (05) : 690 - 694
12345